alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 66, Number 29 (Monday, February 12, 2001)]
[Notices]
[Pages 9855-9856]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-3483]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention and Agency for Toxic 
Substance and Disease Registry


Meeting; Correction

    The Office of the Director of the Centers for Disease Control and 
Prevention (CDC) and Agency for Toxic Substance and Disease Registry 
(ATSDR) announces the following correction.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: In accordance with Departmental policy on consultation 
with(AI/AN) Governments and Organizations, CDC/ATSDR will host this 
meeting to give AI/AN people an opportunity to present their public 
health program needs and priorities. The timing of this meeting will 
allow CDC and ATSDR to consider these needs and priorities in 
developing the FY 2002 budget request.

Correction

    In the Federal Register of January 31, 2001, (Volume 66, Number 21) 
[Notices] Page 8404--``Contact Person for More Information'' email: 
<a href="/cdn-cgi/l/email-protection#0f5c686a7d686a7d4f6c6b6c21686079"><span class="__cf_email__" data-cfemail="5f0c383a2d383a2d1f3c3b3c71383029">[email protected]</span></a>--should read <a href="/cdn-cgi/l/email-protection#ff9e989a8d9d9a8dbf9c9b9cd1989089"><span class="__cf_email__" data-cfemail="80e1e7e5f2e2e5f2c0e3e4e3aee7eff6">[email protected]</span></a>.

[[Page 9856]]

    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: February 2, 2001.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 01-3483 Filed 2-9-01; 8:45 am]
BILLING CODE 4160-19-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 31.1

CERTIFICATION



Certification of President



I, Wm. Lee Popham, President, certify that:



1.

I have reviewed this quarterly report on Form 10-Q of Admiral Financial Corp.;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;



4.

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:



(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)

Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and



5.

The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):



(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.



Dated: May 12, 2010



/s/ Wm. Lee PophamWm. Lee Popham, President
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT MIRACLE CHIROPRATIC & REHAB ) CENTER, LLC, a/a/o DIEUVELA LOUIS ) THOMAS, ) ) Petitioner, ) ) v. ) Case No. 2D18-4179 ) SOUTHERN-OWNERS INSURANCE ) COMPANY, ) ) Respondent. ) ) Opinion filed July 12, 2019. Petition for Writ of Certiorari to the Circuit Court for Polk County; sitting in its appellate capacity. Robert Morris of Eiffert & Associates, P.A., Orlando, for Petitioner. Carri S. Leininger of Williams, Leininger & Cosby, P.A., North Palm Beach, for Respondent.

PER CURIAM.

Denied.

KELLY, MORRIS, and SLEET, JJ., Concur.
EXHIBIT 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection  with the Annual Report of Cadus  Corporation  (the  "Company") on
Form 10-K for the period ending  December 31, 2004 as filed with the  Securities
and  Exchange  Commission  on the date hereof (the  "Report"),  I, David  Blitz,
President and Chief Executive  Officer of the Company,  certify,  pursuant to 18
U.S.C.  ss. 1350, as adopted  pursuant to ss. 906 of the  Sarbanes-Oxley  Act of
2002, that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.

A signed  original of this  written  statement  required by Section 906 has been
provided to Cadus  Corporation  and will be retained  by Cadus  Corporation  and
furnished to the Securities and Exchange Commission or its staff upon request.


David Blitz
President and Chief Executive Officer (Chief
Executive Officer and Chief Financial Officer)
March 29, 2005

The foregoing  certification is furnished  solely pursuant to 18 U.S.C.  Section
1350 and is not being  filed as part of the Report or as a  separate  disclosure
document.
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 1998 AND AS OF
SEPTEMBER 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                    0000911317
<NAME> LAS VEGAS AIRLINES, INC.
<MULTIPLIER>                    1
<CURRENCY>                      US dollars

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              Sep-30-1998
<PERIOD-START>                                 Oct-01-1997
<PERIOD-END>                                   Sep-30-1998
<EXCHANGE-RATE>                                1
<CASH>                                         141,599
<SECURITIES>                                   0
<RECEIVABLES>                                  58,709
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               650,863
<PP&E>                                         37,005
<DEPRECIATION>                                 180,510
<TOTAL-ASSETS>                                 1,244,605
<CURRENT-LIABILITIES>                          2,108,098
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       3,937
<OTHER-SE>                                     (874,851)
<TOTAL-LIABILITY-AND-EQUITY>                   1,255,605
<SALES>                                        1,816,307
<TOTAL-REVENUES>                               0
<CGS>                                          1,845,444
<TOTAL-COSTS>                                  861,073
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             113,419
<INCOME-PRETAX>                                (858,173)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (858,173)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (858,173)
<EPS-BASIC>                                  (.22)
<EPS-DILUTED>                                  (.22)


</TABLE>
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

JEFFREY J. DAVIS, 

Appellant

 v.

COMMONWEALTH OF PENNSYLVANIA, 

Appellee

:

:

:

:

:

:

:

:

:

:

:

No. 23 MAP 2018

Notice of Appeal from the order of the 

Commonwealth Court at No. 670 FR 2016 

dated April 6, 2018 Dismissing and 

Quashing the Petition for Review from the 

Order of the Department of Finance and 

Revenue at No. 1507013 dated July 13, 

2016, exited July 19, 2016

ORDER

PER CURIAM

AND NOW, this 20th day of September, 2018, as Appellant failed to file 

exceptions to the April 6, 2018 order in the Commonwealth Court, the Notice of Appeal 

is quashed. See Pa.R.A.P. 1571(i); Commonwealth v. After Six, Inc., 413 A.2d 1017, 

1022-23 (Pa. 1980) (explaining that exceptions are required to be filed with the 

Commonwealth Court to preserve issues for an appeal to this Court as concerns review 

of a determination of the Board of Finance and Revenue).
United States Court of Appeals

For the Eighth Circuit

___________________________

No. 19-3009

___________________________

William Leroy Sanders

lllllllllllllllllllllPetitioner - Appellant

v.

United States of America

lllllllllllllllllllllRespondent - Appellee

 ____________

Appeal from United States District Court 

for the Southern District of Iowa - Des Moines

 ____________

 Submitted: September 25, 2020

Filed: October 5, 2020

[Unpublished]

____________

Before COLLOTON, BENTON, and KOBES, Circuit Judges. 

____________

PER CURIAM.

William Leroy Sanders appeals after the district court1 denied his 28 U.S.C.

§ 2255 motion, and granted a certificate of appealability on his claim that his sentence

1The Honorable Stephanie M. Rose, United States District Judge for the

Southern District of Iowa.
under the Armed Career Criminal Act (ACCA), 18 U.S.C. § 924(e), is invalid in light

of Johnson v. United States, 576 U.S. 591, 606 (2015) (invalidating residual clause

of ACCA as unconstitutionally vague). Having jurisdiction under 28 U.S.C. § 1291,

this court affirms.

This court concludes Sanders did not meet his burden to show by a

preponderance of the evidence that the residual clause led the sentencing court to

apply the ACCA enhancement. See Dembry v. United States, 914 F.3d 1185, 1187

(8th Cir. 2019) (standard of review); Golinveaux v. United States, 915 F.3d 564, 567-

68 (8th Cir. 2019) (movant bringing Johnson claim must show by preponderance of

evidence that residual clause led sentencing court to apply ACCA enhancement). 

The judgment is affirmed.

______________________________

-2-
[Federal Register Volume 66, Number 29 (Monday, February 12, 2001)]
[Notices]
[Page 9872]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-3466]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussion could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel
    Date: February 27, 2001.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Hotel, Congressional Salon Conference 
Room, 5100 Pook's Hill Road, Bethesda, MD.
    Contract Person: Paula S. Strickland, PhD., Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, NIH, Solar Building, Room 4C02, 6003 Executive 
Boulevard MSC 7610, Bethesda, MD 20892-7610, 301-402-0643.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, Transplantation, Research; 93.856, Microbiology 
and Infectious Diseases Research, National Institutes of Health, 
HHS)


    Dated: February 2, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-3466 Filed 2-09-01; 8:45 am]
BILLING CODE 4140-01-M
<PAGE>

                                  EXHIBIT 21

Gundle/SLT Environmental, Inc.

SUBSIDIARY LIST:

GSE International, Inc.
GSE Lining Technology, Inc.
GSE Foreign Sales Ltd.
GSE Clay Lining Technology Co.
GSE Lining Technology Pte. Ltd.
GSE Lining Technology GmbH
GSE Lining Technology Pty Ltd.
GSE(UK) Ltd.
GSE Lining Technology Limited
Gundle Environmental Ltd.
SGS Geosystems Limited
SGS Holdings Limited
Geoplastics Gesellschaft Fur Abdichtungssysteme mbH Gundle GmbH
Hyma/GSE Lining Technology Co.
Hyme/GSE Manufacturing Co.
GSE Lining Technology Company Limited
GSE Gulf Offshore Ltd.
GSE Lining Technology S.L.
GSE GULF FZE

                                       1
Electronically Filed

Intermediate Court of Appeals

CAAP-14-0001121

15-MAY-2017

11:44 AM
<PAGE>   1
                       EXHIBIT 23.2 - CONSENT OF KPMG LLP


                         INDEPENDENT AUDITORS' CONSENT

The Board of Directors
National TechTeam, Inc.:

We consent to incorporation by reference in the Registration Statements on Form 
S-3 (Nos. 333-23745, 333-43807 and 333-53807) and the Registration Statements 
on Form S-8 (Nos. 333-04731 and 333-04733) of National Tech Team, Inc., of our 
report dated February 9, 1999, related to the balance sheets and statements of 
operations, partners' capital and cash flows for the year ended December 31, 
1998 and for the period from inception (October 1, 1997) through December 31, 
1997 GE TechTeam LP, which report appears in the 1998 Annual Report on Form 
10-K of National Tech Team, Inc.


                                                                   /s/ KPMG LLP

Dallas, Texas
March 29, 1999
#### UNITED STATES of America, Plaintiff-Appellee v. Jose Andres GONZALEZ, Defendant-Appellant *859United States of America, Plaintiff-Appellee v. Jose Andres Gonzalez, also known as Jose Andrew Gonzalez, Jr., Defendant-Appellant.

Nos. 10-50231, 10-50238

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

Dec. 29, 2010.

Joseph H. Gay, Jr., Assistant U.S. Attorney, U.S. Attorney’s Office, San Antonio, TX, for Plaintiff-Appellee.

Judy Fulmer Madewell, Assistant Federal Public Defender, Henry Joseph Bemporad, Federal Public Defender, Federal Public Defender’s Office, San Antonio, TX, for Defendant-Appellant.

Before JOLLY, GARZA and STEWART, Circuit Judges.

PER CURIAM: *

Jose Andres Gonzalez was convicted following entry of a guilty plea to a charge of illegal reentry following removal and was sentenced to a sentence of 18 months of imprisonment. Gonzalez’s supervised release was revoked, and he was sentenced to serve 24 months of imprisonment. The district court ordered the sentences to run consecutively to each other and to any future imprisonment term imposed in a pending state case.

Gonzalez now appeals, presenting arguments that he concedes are foreclosed by *United States v. Brown,*920 F.2d 1212, 1216-17 (5th Cir.1991), *abrogated on other grounds by United States v. Candia,*454 F.3d 468, 472-73 (5th Cir.2006), which held that a district court may order a term of imprisonment to run consecutively with an unimposed state sentence. Accordingly, the Government’s motion for summary affirmance is GRANTED, its alternative motion for an extension of time to file a brief is DENIED, and the judgment of the district court and order revoking supervised release and imposing sentence are AFFIRMED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
EXHIBIT
      23.2




CONSENT
      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM




We
      have
      issued our report dated February 18, 2005 accompanying the consolidated
      financial statements of Cadus Corporation and subsidiary included in the Annual
      Report of Cadus Corporation of Form 10-K for the year ended December 31, 2006.
      We hereby consent to incorporation by reference of said report in the
      Registration Statements of Cadus Corporation on Forms S-8 (File No. 333-21871,
      effective February 14, 1997 and File No. 333-58151, effective June 30, 1998).






/s/
      GRANT
      THORNTON LLP





New
      York,
      New York


March
      26,
      2007
Exhibit 10.3


                                 AMENDMENT NO. 3
                         (DATED EFFECTIVE MAY 25, 2006)
                                       TO
                  SCHOLASTIC CORPORATION 1997 OUTSIDE DIRECTORS
                                STOCK OPTION PLAN
                    (AMENDED AND RESTATED AS OF MAY 25, 1999)

                  1.       Section 3 of the Plan is amended FIRST by deleting
the first paragraph appearing therein and SECOND by restating the first sentence
of the second paragraph to read as follows:

                  Except as provided in Section 5 below, an option may be
                  exercised, in whole or in part at any time and from time or
                  time during the period beginning with the date the option
                  first becomes exercisable and ending on the date the option
                  expires, by giving written notice of exercise to the Company
                  specifying the number of shares of Common Stock to be
                  purchased.

                  2.       Section 5 of the Plan is amended by restating
subsection (c)(4) to read as follows:

                  Notwithstanding the provisions of subsections (b) and (c)
                  above of this Section 5, in no event shall any option granted
                  under the Plan be exercised within six months after the date
                  of grant.

                  3.       Except as otherwise provided herein, the Plan is
ratified and confirmed and shall continue in full force and effect.

                  The foregoing amendment was duly approved by resolution of the
Board of Directors of Scholastic Corporation at its meeting held on May 25,
2006.
[Federal Register Volume 66, Number 29 (Monday, February 12, 2001)]
[Notices]
[Page 9870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-3469]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institutes of Health; National Eye Institute; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Eye Institute Special Emphasis 
Panel.
    Date: March 14, 2001.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 6120 Executive Blvd., Suite 350, Rockville, MD 20892.
    Contact Person: Andrew P Mariani, PhD., Chief, Scientific Review 
Branch, 6120 Executive Blvd, Suite 350, Rockville, MD 20892, 301/
496-5561.


(Catalogue of Federal Domestic Assistance Program No. 93.867, Vision 
Research, National Institutes of Health, HHS)

    Dated: February 1, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-3469 Filed 2-9-01; 8:45 am]
BILLING CODE 4140-01-M
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1796 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 1796

To amend title 38, United States Code, to increase the rate of special 
pension payable to persons who have received the Congressional Medal of 
                                 Honor.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 21, 1993

Mr. Spence (for himself and Mr. McNulty) introduced the following bill; 
        which was referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
To amend title 38, United States Code, to increase the rate of special 
pension payable to persons who have received the Congressional Medal of 
                                 Honor.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. INCREASE IN RATE OF SPECIAL PENSION FOR PERSONS ON THE MEDAL 
              OF HONOR ROLL.

    (a) In General.--Section 562(a) of title 38, United States Code, is 
amended by striking ``$200'' and inserting ``$500''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
apply with respect to months beginning after the date of the enactment 
of this Act.

                                 <all>
```